

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.71422380 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.59713539 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.43426884 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.43426884 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.42170279 |
| 6 | detection of other organism (GO:0098543) | 4.64439969 |
| 7 | detection of bacterium (GO:0016045) | 4.62483241 |
| 8 | immunoglobulin mediated immune response (GO:0016064) | 4.55708944 |
| 9 | * regulation of B cell receptor signaling pathway (GO:0050855) | 4.48306128 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.36127229 |
| 11 | positive regulation of B cell differentiation (GO:0045579) | 4.23731918 |
| 12 | * B cell receptor signaling pathway (GO:0050853) | 4.21354839 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.09542808 |
| 14 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.06234940 |
| 15 | leukocyte aggregation (GO:0070486) | 4.05530726 |
| 16 | * regulation of B cell differentiation (GO:0045577) | 3.99681488 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.81642826 |
| 18 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.80428052 |
| 19 | B cell mediated immunity (GO:0019724) | 3.76893303 |
| 20 | detection of external biotic stimulus (GO:0098581) | 3.75575496 |
| 21 | response to host immune response (GO:0052572) | 3.64141684 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.64141684 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.62872247 |
| 24 | negative regulation of phagocytosis (GO:0050765) | 3.62117648 |
| 25 | regulation of mast cell degranulation (GO:0043304) | 3.61838492 |
| 26 | interferon-gamma production (GO:0032609) | 3.56199404 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.54930215 |
| 28 | negative thymic T cell selection (GO:0045060) | 3.53491111 |
| 29 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.53148190 |
| 30 | cellular response to zinc ion (GO:0071294) | 3.52734267 |
| 31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.52287724 |
| 32 | negative regulation of cell killing (GO:0031342) | 3.52287724 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49582273 |
| 34 | respiratory burst (GO:0045730) | 3.49313387 |
| 35 | * negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.48626235 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47272682 |
| 37 | defense response to protozoan (GO:0042832) | 3.45370128 |
| 38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.44796031 |
| 39 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.42522069 |
| 40 | negative T cell selection (GO:0043383) | 3.41492402 |
| 41 | response to interleukin-15 (GO:0070672) | 3.34879491 |
| 42 | neutrophil activation involved in immune response (GO:0002283) | 3.33935184 |
| 43 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.33053738 |
| 44 | response to host (GO:0075136) | 3.33053738 |
| 45 | response to host defenses (GO:0052200) | 3.33053738 |
| 46 | * negative regulation of leukocyte mediated immunity (GO:0002704) | 3.31294250 |
| 47 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.30859178 |
| 48 | detection of biotic stimulus (GO:0009595) | 3.29691546 |
| 49 | microglial cell activation (GO:0001774) | 3.28254213 |
| 50 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27683120 |
| 51 | cellular response to interleukin-15 (GO:0071350) | 3.27483407 |
| 52 | response to peptidoglycan (GO:0032494) | 3.25784240 |
| 53 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.25654434 |
| 54 | response to protozoan (GO:0001562) | 3.21773500 |
| 55 | T cell migration (GO:0072678) | 3.18924463 |
| 56 | mast cell activation (GO:0045576) | 3.18630280 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.18222944 |
| 58 | positive regulation of interferon-alpha production (GO:0032727) | 3.17995711 |
| 59 | * interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17768102 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 3.16976545 |
| 61 | ribosomal small subunit assembly (GO:0000028) | 3.16714771 |
| 62 | regulation of T cell tolerance induction (GO:0002664) | 3.16286926 |
| 63 | detection of molecule of bacterial origin (GO:0032490) | 3.16266069 |
| 64 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.13760192 |
| 65 | mature B cell differentiation (GO:0002335) | 3.13447429 |
| 66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09599032 |
| 67 | * response to type I interferon (GO:0034340) | 3.09079031 |
| 68 | * type I interferon signaling pathway (GO:0060337) | 3.08690871 |
| 69 | * cellular response to type I interferon (GO:0071357) | 3.08690871 |
| 70 | mature B cell differentiation involved in immune response (GO:0002313) | 3.08637230 |
| 71 | leukocyte degranulation (GO:0043299) | 3.06314981 |
| 72 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.05159786 |
| 73 | regulation of tolerance induction (GO:0002643) | 3.05156816 |
| 74 | * regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.04953330 |
| 75 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.02542038 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.02542038 |
| 77 | macrophage activation (GO:0042116) | 3.01589604 |
| 78 | regulation of interferon-alpha production (GO:0032647) | 3.00196467 |
| 79 | tolerance induction (GO:0002507) | 2.99191480 |
| 80 | modulation by symbiont of host immune response (GO:0052553) | 2.98500265 |
| 81 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98500265 |
| 82 | modulation by symbiont of host defense response (GO:0052031) | 2.98500265 |
| 83 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98500265 |
| 84 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98500265 |
| 85 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98500265 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98093147 |
| 87 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98028066 |
| 88 | thymic T cell selection (GO:0045061) | 2.96868990 |
| 89 | negative regulation of innate immune response (GO:0045824) | 2.95634471 |
| 90 | cellular extravasation (GO:0045123) | 2.94164359 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.93405099 |
| 92 | neutrophil mediated immunity (GO:0002446) | 2.91676682 |
| 93 | myeloid dendritic cell activation (GO:0001773) | 2.91262223 |
| 94 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.87939538 |
| 95 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86719877 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.85779775 |
| 97 | positive regulation of isotype switching (GO:0045830) | 2.83484783 |
| 98 | neutrophil activation (GO:0042119) | 2.81667017 |
| 99 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76527964 |
| 100 | actin nucleation (GO:0045010) | 2.75593181 |
| 101 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73918147 |
| 102 | regulation of antigen processing and presentation (GO:0002577) | 2.73394881 |
| 103 | response to interferon-beta (GO:0035456) | 2.72607150 |
| 104 | T cell homeostasis (GO:0043029) | 2.71936968 |
| 105 | cellular response to interferon-beta (GO:0035458) | 2.71135980 |
| 106 | positive regulation of lamellipodium assembly (GO:0010592) | 2.70123558 |
| 107 | myeloid cell activation involved in immune response (GO:0002275) | 2.69595234 |
| 108 | positive regulation of macrophage differentiation (GO:0045651) | 2.69126625 |
| 109 | T cell selection (GO:0045058) | 2.67348927 |
| 110 | leukocyte cell-cell adhesion (GO:0007159) | 2.64712014 |
| 111 | lymphocyte homeostasis (GO:0002260) | 2.63733603 |
| 112 | response to muramyl dipeptide (GO:0032495) | 2.63704843 |
| 113 | negative regulation of B cell proliferation (GO:0030889) | 2.63287169 |
| 114 | positive regulation of mast cell activation (GO:0033005) | 2.63218940 |
| 115 | natural killer cell activation (GO:0030101) | 2.62625697 |
| 116 | macrophage activation involved in immune response (GO:0002281) | 2.60363584 |
| 117 | positive T cell selection (GO:0043368) | 2.60316087 |
| 118 | granulocyte activation (GO:0036230) | 2.59889335 |
| 119 | positive regulation of interferon-beta production (GO:0032728) | 2.59633703 |
| 120 | myeloid dendritic cell differentiation (GO:0043011) | 2.59598727 |
| 121 | positive regulation of B cell activation (GO:0050871) | 2.58529556 |
| 122 | regulation of necroptotic process (GO:0060544) | 2.57700529 |
| 123 | pinocytosis (GO:0006907) | 2.56848830 |
| 124 | positive regulation of interleukin-2 production (GO:0032743) | 2.56658889 |
| 125 | germinal center formation (GO:0002467) | 2.52952126 |
| 126 | * T cell costimulation (GO:0031295) | 2.51911365 |
| 127 | B cell proliferation (GO:0042100) | 2.51684444 |
| 128 | regulation of mast cell activation (GO:0033003) | 2.51566232 |
| 129 | mast cell degranulation (GO:0043303) | 2.50567431 |
| 130 | mast cell activation involved in immune response (GO:0002279) | 2.50567431 |
| 131 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.50405987 |
| 132 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.49350527 |
| 133 | * lymphocyte costimulation (GO:0031294) | 2.48795720 |
| 134 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.48683700 |
| 135 | natural killer cell differentiation (GO:0001779) | 2.48433065 |
| 136 | * regulation of T cell receptor signaling pathway (GO:0050856) | 2.48224958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89748072 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.84005991 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.84738039 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82605250 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.72802067 |
| 6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21514281 |
| 7 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.14056388 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03496897 |
| 9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96100051 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.91954206 |
| 11 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.65247917 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.62414197 |
| 13 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61465458 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.51491682 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.51447311 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45898560 |
| 17 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.44344642 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41809772 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.40110819 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.39822759 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.31214428 |
| 22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28654233 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.21639151 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.18616809 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15569627 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.12267905 |
| 27 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.09084620 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07114913 |
| 29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05626638 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 2.01533939 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01121932 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.00621502 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.97868805 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93419646 |
| 35 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.86161246 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.85375365 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84164230 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.82812302 |
| 39 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81744249 |
| 40 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.81171335 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78764785 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.78302801 |
| 43 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72256900 |
| 44 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.68048119 |
| 45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.67781109 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64051623 |
| 47 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57631548 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53702249 |
| 49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50926233 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49805921 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.48197232 |
| 52 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.45473262 |
| 53 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43405164 |
| 54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.42131743 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41811219 |
| 56 | * MAF_26560356_Chip-Seq_TH2_Human | 1.40824544 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40105047 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37493453 |
| 59 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.35962422 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.35246668 |
| 61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.31653530 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31279336 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.31182909 |
| 64 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30845697 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28747551 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28697787 |
| 67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.27849180 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23213586 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20596439 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19093971 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17802114 |
| 72 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.15738063 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15379422 |
| 74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.15009636 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.14874189 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.14511998 |
| 77 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13646244 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.12131660 |
| 79 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11031058 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10631586 |
| 81 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09652915 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07759559 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.07647650 |
| 84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06467165 |
| 85 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.05790995 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05563980 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04670713 |
| 88 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.04568336 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04171842 |
| 90 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03569788 |
| 91 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02076131 |
| 92 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01942470 |
| 93 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99710919 |
| 94 | GATA3_26560356_Chip-Seq_TH2_Human | 0.99639775 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.99032690 |
| 96 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97591109 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97311380 |
| 98 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97311247 |
| 99 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96687912 |
| 100 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.96407720 |
| 101 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96081181 |
| 102 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95064860 |
| 103 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.94675255 |
| 104 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93605423 |
| 105 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93391782 |
| 106 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92360092 |
| 107 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.91755630 |
| 108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91737718 |
| 109 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.91583331 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.90546534 |
| 111 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89278641 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.88643197 |
| 113 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88607652 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87926413 |
| 115 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85046149 |
| 116 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.83785023 |
| 117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83056441 |
| 118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.82979601 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82261321 |
| 120 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82044065 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82020015 |
| 122 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.81965690 |
| 123 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81461824 |
| 124 | P300_27268052_Chip-Seq_Bcells_Human | 0.81158983 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.86384365 |
| 2 | MP0005671_abnormal_response_to | 3.51923567 |
| 3 | * MP0001800_abnormal_humoral_immune | 3.33600496 |
| 4 | MP0000685_abnormal_immune_system | 3.27848480 |
| 5 | MP0001790_abnormal_immune_system | 3.18208438 |
| 6 | MP0005387_immune_system_phenotype | 3.18208438 |
| 7 | MP0003436_decreased_susceptibility_to | 3.06111826 |
| 8 | * MP0005000_abnormal_immune_tolerance | 3.01275317 |
| 9 | * MP0009785_altered_susceptibility_to | 2.96549588 |
| 10 | * MP0002452_abnormal_antigen_presenting | 2.94568726 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.81693280 |
| 12 | * MP0002723_abnormal_immune_serum | 2.77489257 |
| 13 | * MP0002420_abnormal_adaptive_immunity | 2.75093303 |
| 14 | * MP0005025_abnormal_response_to | 2.73088348 |
| 15 | * MP0001819_abnormal_immune_cell | 2.71757328 |
| 16 | MP0002396_abnormal_hematopoietic_system | 2.67867704 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.63379611 |
| 18 | MP0002419_abnormal_innate_immunity | 2.55431610 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.51565327 |
| 20 | MP0006082_CNS_inflammation | 2.39901622 |
| 21 | * MP0000716_abnormal_immune_system | 2.31033670 |
| 22 | MP0003303_peritoneal_inflammation | 2.30361521 |
| 23 | * MP0000689_abnormal_spleen_morphology | 2.21243621 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.17806622 |
| 25 | * MP0002405_respiratory_system_inflammati | 2.09501936 |
| 26 | * MP0002722_abnormal_immune_system | 2.06516147 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.02813984 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.01613887 |
| 29 | * MP0002429_abnormal_blood_cell | 1.99051467 |
| 30 | MP0001853_heart_inflammation | 1.92367721 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.87594714 |
| 32 | MP0001873_stomach_inflammation | 1.85051160 |
| 33 | MP0003724_increased_susceptibility_to | 1.84042971 |
| 34 | * MP0001845_abnormal_inflammatory_respons | 1.81319817 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.72014566 |
| 36 | MP0004947_skin_inflammation | 1.67482146 |
| 37 | MP0002006_tumorigenesis | 1.65573814 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.58305287 |
| 39 | * MP0000703_abnormal_thymus_morphology | 1.57252975 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.55824260 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.55824260 |
| 42 | MP0008260_abnormal_autophagy | 1.52112585 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.51886109 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.50676040 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.49395901 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.49123686 |
| 47 | MP0000490_abnormal_crypts_of | 1.48214713 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.46349335 |
| 49 | MP0008057_abnormal_DNA_replication | 1.42677411 |
| 50 | MP0008469_abnormal_protein_level | 1.40808693 |
| 51 | MP0004510_myositis | 1.34771428 |
| 52 | MP0005451_abnormal_body_composition | 1.34607439 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.33827435 |
| 54 | MP0003693_abnormal_embryo_hatching | 1.33447299 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.33271121 |
| 56 | MP0000858_altered_metastatic_potential | 1.31769457 |
| 57 | MP0009278_abnormal_bone_marrow | 1.31714959 |
| 58 | MP0003866_abnormal_defecation | 1.30925023 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.30167202 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.27085696 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.16230163 |
| 62 | MP0003448_altered_tumor_morphology | 1.11928662 |
| 63 | MP0000343_altered_response_to | 1.07635087 |
| 64 | MP0010094_abnormal_chromosome_stability | 1.04999501 |
| 65 | MP0002132_abnormal_respiratory_system | 1.01382344 |
| 66 | MP0009764_decreased_sensitivity_to | 1.00536335 |
| 67 | * MP0005310_abnormal_salivary_gland | 1.00431803 |
| 68 | MP0004883_abnormal_blood_vessel | 0.99654604 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 0.98648303 |
| 70 | * MP0003077_abnormal_cell_cycle | 0.96973141 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.94323047 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 0.93346634 |
| 73 | * MP0002933_joint_inflammation | 0.91676806 |
| 74 | MP0000604_amyloidosis | 0.90921035 |
| 75 | MP0008007_abnormal_cellular_replicative | 0.90696190 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.89669960 |
| 77 | MP0010307_abnormal_tumor_latency | 0.86231518 |
| 78 | MP0009840_abnormal_foam_cell | 0.83665134 |
| 79 | MP0009763_increased_sensitivity_to | 0.82940302 |
| 80 | MP0003690_abnormal_glial_cell | 0.79811891 |
| 81 | MP0001851_eye_inflammation | 0.76682628 |
| 82 | * MP0000313_abnormal_cell_death | 0.75856222 |
| 83 | MP0003111_abnormal_nucleus_morphology | 0.74948695 |
| 84 | MP0002009_preneoplasia | 0.73263532 |
| 85 | MP0000371_diluted_coat_color | 0.72174464 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.71199498 |
| 87 | MP0005164_abnormal_response_to | 0.70712261 |
| 88 | MP0003045_fibrosis | 0.70656871 |
| 89 | MP0008058_abnormal_DNA_repair | 0.69711848 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.66509532 |
| 91 | MP0005023_abnormal_wound_healing | 0.66231048 |
| 92 | MP0003075_altered_response_to | 0.66194249 |
| 93 | MP0003828_pulmonary_edema | 0.65417043 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 0.65055481 |
| 95 | MP0002254_reproductive_system_inflammat | 0.62863248 |
| 96 | MP0008004_abnormal_stomach_pH | 0.62595084 |
| 97 | MP0000249_abnormal_blood_vessel | 0.61453645 |
| 98 | MP0008874_decreased_physiological_sensi | 0.60812854 |
| 99 | MP0005166_decreased_susceptibility_to | 0.60766375 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.58641689 |
| 101 | MP0005390_skeleton_phenotype | 0.58209104 |
| 102 | MP0001986_abnormal_taste_sensitivity | 0.57321593 |
| 103 | MP0004264_abnormal_extraembryonic_tissu | 0.56972797 |
| 104 | * MP0002095_abnormal_skin_pigmentation | 0.56604636 |
| 105 | MP0008873_increased_physiological_sensi | 0.55179567 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.54615514 |
| 107 | MP0000598_abnormal_liver_morphology | 0.54482166 |
| 108 | MP0000609_abnormal_liver_physiology | 0.53842670 |
| 109 | MP0003795_abnormal_bone_structure | 0.53562609 |
| 110 | MP0001663_abnormal_digestive_system | 0.53285886 |
| 111 | MP0000477_abnormal_intestine_morphology | 0.53184124 |
| 112 | MP0000350_abnormal_cell_proliferation | 0.53009062 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.52895196 |
| 114 | MP0004381_abnormal_hair_follicle | 0.52652528 |
| 115 | MP0003091_abnormal_cell_migration | 0.51827022 |
| 116 | MP0005319_abnormal_enzyme/_coenzyme | 0.49690810 |
| 117 | MP0005381_digestive/alimentary_phenotyp | 0.44890310 |
| 118 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40013441 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.39499847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.47622811 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.01322657 |
| 3 | IgM deficiency (HP:0002850) | 4.85477031 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.83897466 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.57905344 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.49405737 |
| 7 | Recurrent bronchitis (HP:0002837) | 4.41300258 |
| 8 | Recurrent viral infections (HP:0004429) | 4.18535180 |
| 9 | Myositis (HP:0100614) | 4.09772822 |
| 10 | Cellulitis (HP:0100658) | 4.05197458 |
| 11 | Recurrent fungal infections (HP:0002841) | 4.04496531 |
| 12 | Chronic otitis media (HP:0000389) | 4.03788332 |
| 13 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82136968 |
| 14 | Meningitis (HP:0001287) | 3.73556527 |
| 15 | Gastrointestinal infarctions (HP:0005244) | 3.61736748 |
| 16 | Thrombocytosis (HP:0001894) | 3.59448324 |
| 17 | Recurrent skin infections (HP:0001581) | 3.58509710 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.55690956 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 3.54838308 |
| 20 | Inflammation of the large intestine (HP:0002037) | 3.53603902 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 3.50588365 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49162117 |
| 23 | Vasculitis (HP:0002633) | 3.47420578 |
| 24 | Colitis (HP:0002583) | 3.46787031 |
| 25 | Panhypogammaglobulinemia (HP:0003139) | 3.46564968 |
| 26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44521734 |
| 27 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44521734 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 3.42806294 |
| 29 | Lymphopenia (HP:0001888) | 3.39336576 |
| 30 | Nasal polyposis (HP:0100582) | 3.39333114 |
| 31 | Abnormality of T cells (HP:0002843) | 3.37567582 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.33101279 |
| 33 | Obstructive lung disease (HP:0006536) | 3.32585686 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 3.32585686 |
| 35 | Recurrent sinusitis (HP:0011108) | 3.31088299 |
| 36 | Petechiae (HP:0000967) | 3.15839040 |
| 37 | Abnormality of macrophages (HP:0004311) | 3.14799770 |
| 38 | T lymphocytopenia (HP:0005403) | 3.10992723 |
| 39 | Abnormality of T cell number (HP:0011839) | 3.08187741 |
| 40 | Abnormality of the nasal mucosa (HP:0000433) | 3.06024057 |
| 41 | Keratoconjunctivitis sicca (HP:0001097) | 3.00130612 |
| 42 | Orchitis (HP:0100796) | 2.99811606 |
| 43 | Combined immunodeficiency (HP:0005387) | 2.93346721 |
| 44 | Pustule (HP:0200039) | 2.90195342 |
| 45 | IgG deficiency (HP:0004315) | 2.88144685 |
| 46 | Thyroiditis (HP:0100646) | 2.87589282 |
| 47 | Spontaneous hematomas (HP:0007420) | 2.87383335 |
| 48 | Gingivitis (HP:0000230) | 2.79981664 |
| 49 | Keratoconjunctivitis (HP:0001096) | 2.77729231 |
| 50 | Stomatitis (HP:0010280) | 2.77209897 |
| 51 | Chronic diarrhea (HP:0002028) | 2.73521503 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.70513452 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.70288685 |
| 54 | Osteomyelitis (HP:0002754) | 2.68416090 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.62057118 |
| 56 | Recurrent pneumonia (HP:0006532) | 2.61381796 |
| 57 | IgA deficiency (HP:0002720) | 2.59619744 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.59411381 |
| 59 | Epistaxis (HP:0000421) | 2.58839484 |
| 60 | Pulmonary infiltrates (HP:0002113) | 2.57970037 |
| 61 | Recurrent lower respiratory tract infections (HP:0002783) | 2.56450519 |
| 62 | Leukocytosis (HP:0001974) | 2.56347775 |
| 63 | Emphysema (HP:0002097) | 2.52569797 |
| 64 | Lymphoma (HP:0002665) | 2.52139817 |
| 65 | Severe combined immunodeficiency (HP:0004430) | 2.51826557 |
| 66 | Chronic sinusitis (HP:0011109) | 2.48723634 |
| 67 | Encephalitis (HP:0002383) | 2.48340348 |
| 68 | Bronchitis (HP:0012387) | 2.47226632 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.45887461 |
| 70 | Optic neuritis (HP:0100653) | 2.45887461 |
| 71 | Chest pain (HP:0100749) | 2.44358763 |
| 72 | Increased cerebral lipofuscin (HP:0011813) | 2.43893671 |
| 73 | B lymphocytopenia (HP:0010976) | 2.43259762 |
| 74 | Abnormality of B cell number (HP:0010975) | 2.43259762 |
| 75 | Pulmonary embolism (HP:0002204) | 2.42849933 |
| 76 | Periodontitis (HP:0000704) | 2.39135922 |
| 77 | Papilloma (HP:0012740) | 2.37990155 |
| 78 | Verrucae (HP:0200043) | 2.37990155 |
| 79 | Purpura (HP:0000979) | 2.36803604 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.36440546 |
| 81 | Increased IgE level (HP:0003212) | 2.35760253 |
| 82 | Restrictive lung disease (HP:0002091) | 2.34104952 |
| 83 | Impaired platelet aggregation (HP:0003540) | 2.31078042 |
| 84 | Abnormal platelet function (HP:0011869) | 2.31078042 |
| 85 | Abnormality of the prostate (HP:0008775) | 2.28020338 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.27717198 |
| 87 | Abnormality of eosinophils (HP:0001879) | 2.27469581 |
| 88 | Urticaria (HP:0001025) | 2.26087324 |
| 89 | Sepsis (HP:0100806) | 2.25963700 |
| 90 | Hypergammaglobulinemia (HP:0010702) | 2.22552399 |
| 91 | Viral hepatitis (HP:0006562) | 2.22378853 |
| 92 | Eosinophilia (HP:0001880) | 2.22175779 |
| 93 | Episodic fever (HP:0001954) | 2.21523679 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.21281277 |
| 95 | Anorexia (HP:0002039) | 2.18920280 |
| 96 | Granulocytopenia (HP:0001913) | 2.18648414 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.18228123 |
| 98 | Skin ulcer (HP:0200042) | 2.18085839 |
| 99 | Arterial thrombosis (HP:0004420) | 2.17660094 |
| 100 | Gingival bleeding (HP:0000225) | 2.17135416 |
| 101 | Increased serum ferritin (HP:0003281) | 2.17119550 |
| 102 | Leukopenia (HP:0001882) | 2.16171863 |
| 103 | Systemic lupus erythematosus (HP:0002725) | 2.15153636 |
| 104 | Gangrene (HP:0100758) | 2.14435017 |
| 105 | Aplastic anemia (HP:0001915) | 2.12659470 |
| 106 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11202774 |
| 107 | Hemoptysis (HP:0002105) | 2.09343205 |
| 108 | Increased IgM level (HP:0003496) | 2.08113858 |
| 109 | Premature loss of primary teeth (HP:0006323) | 2.07731348 |
| 110 | Reduced antithrombin III activity (HP:0001976) | 2.04171548 |
| 111 | Agnosia (HP:0010524) | 2.03614863 |
| 112 | Hypochromic anemia (HP:0001931) | 2.03399121 |
| 113 | Skin rash (HP:0000988) | 2.03244865 |
| 114 | Dysostosis multiplex (HP:0000943) | 2.02865063 |
| 115 | Loss of speech (HP:0002371) | 2.02434187 |
| 116 | Arthralgia (HP:0002829) | 2.01043168 |
| 117 | Amyloidosis (HP:0011034) | 1.99505567 |
| 118 | Amaurosis fugax (HP:0100576) | 1.99423265 |
| 119 | Glomerulopathy (HP:0100820) | 1.98579751 |
| 120 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.93921435 |
| 121 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.93921435 |
| 122 | Abnormality of glycolipid metabolism (HP:0010969) | 1.93921435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.09453817 |
| 2 | BLK | 3.19666772 |
| 3 | ERN1 | 2.91983587 |
| 4 | CSF1R | 2.91686020 |
| 5 | PRPF4B | 2.84731981 |
| 6 | KIT | 2.62501028 |
| 7 | STK10 | 2.45835843 |
| 8 | TYK2 | 2.44979512 |
| 9 | GRK6 | 2.42571190 |
| 10 | BTK | 2.41242804 |
| 11 | IRAK4 | 2.38126093 |
| 12 | ZAP70 | 2.30003660 |
| 13 | TXK | 2.20780580 |
| 14 | MAP3K14 | 2.13071614 |
| 15 | TBK1 | 2.08451940 |
| 16 | SYK | 2.05215910 |
| 17 | TGFBR2 | 2.00037585 |
| 18 | TEC | 1.98912971 |
| 19 | JAK3 | 1.96791490 |
| 20 | RIPK4 | 1.80083642 |
| 21 | IKBKE | 1.75455724 |
| 22 | CDK12 | 1.65601406 |
| 23 | ITK | 1.63184587 |
| 24 | CSK | 1.62623876 |
| 25 | IKBKB | 1.57278818 |
| 26 | NME2 | 1.48845921 |
| 27 | MAP3K11 | 1.48159558 |
| 28 | HCK | 1.45389307 |
| 29 | LRRK2 | 1.41828713 |
| 30 | MAP3K10 | 1.41651824 |
| 31 | JAK1 | 1.41069606 |
| 32 | FLT3 | 1.39942606 |
| 33 | * LCK | 1.36775932 |
| 34 | EEF2K | 1.34048904 |
| 35 | MATK | 1.31560324 |
| 36 | MAP3K13 | 1.31341500 |
| 37 | KDR | 1.30349749 |
| 38 | TAOK1 | 1.29286194 |
| 39 | * LYN | 1.29091067 |
| 40 | IRAK3 | 1.27873775 |
| 41 | MAP3K3 | 1.26195903 |
| 42 | TESK2 | 1.24513334 |
| 43 | MAP2K3 | 1.23561520 |
| 44 | FES | 1.23203976 |
| 45 | SMG1 | 1.22267798 |
| 46 | CLK1 | 1.18721107 |
| 47 | BMPR2 | 1.12157137 |
| 48 | MAP3K1 | 1.07553810 |
| 49 | PIM2 | 1.02153974 |
| 50 | PIM1 | 1.00655503 |
| 51 | TAOK2 | 1.00462316 |
| 52 | ACVR1B | 0.98845314 |
| 53 | RPS6KA4 | 0.96633303 |
| 54 | TAOK3 | 0.93495721 |
| 55 | CHUK | 0.91571485 |
| 56 | NEK2 | 0.89118788 |
| 57 | FGFR4 | 0.84772127 |
| 58 | PKN2 | 0.82655331 |
| 59 | FGFR3 | 0.81874633 |
| 60 | TNK2 | 0.76577781 |
| 61 | TGFBR1 | 0.76083127 |
| 62 | MAPK12 | 0.74438357 |
| 63 | MST4 | 0.73978691 |
| 64 | NLK | 0.73841261 |
| 65 | GRK1 | 0.73171385 |
| 66 | ADRBK2 | 0.72821722 |
| 67 | MARK2 | 0.72109247 |
| 68 | KSR2 | 0.70022767 |
| 69 | STK4 | 0.69139791 |
| 70 | MAP2K6 | 0.68193545 |
| 71 | CDC42BPA | 0.67949387 |
| 72 | CDK19 | 0.67294091 |
| 73 | PDPK1 | 0.65462225 |
| 74 | SIK2 | 0.64624294 |
| 75 | YES1 | 0.64208531 |
| 76 | PRKD2 | 0.63328991 |
| 77 | JAK2 | 0.63076556 |
| 78 | IRAK1 | 0.61019770 |
| 79 | CDK4 | 0.60641181 |
| 80 | GRK7 | 0.58485801 |
| 81 | MARK3 | 0.58229287 |
| 82 | EIF2AK3 | 0.57693329 |
| 83 | HIPK2 | 0.57340315 |
| 84 | PAK4 | 0.56891853 |
| 85 | MAP3K8 | 0.56071868 |
| 86 | EPHB1 | 0.56001876 |
| 87 | * FYN | 0.54550287 |
| 88 | EIF2AK1 | 0.52331404 |
| 89 | IRAK2 | 0.51647251 |
| 90 | RPS6KB2 | 0.51082020 |
| 91 | MAP3K5 | 0.47124624 |
| 92 | CDK7 | 0.46758150 |
| 93 | PRKCD | 0.46743114 |
| 94 | MAPK4 | 0.46412249 |
| 95 | TRIB3 | 0.46147846 |
| 96 | MAPKAPK2 | 0.46113971 |
| 97 | RPS6KL1 | 0.45818794 |
| 98 | RPS6KC1 | 0.45818794 |
| 99 | MOS | 0.44839906 |
| 100 | PTK6 | 0.44773119 |
| 101 | NEK9 | 0.43866961 |
| 102 | PIK3CG | 0.43776358 |
| 103 | MAP3K7 | 0.42637498 |
| 104 | SIK1 | 0.42533394 |
| 105 | SIK3 | 0.40912077 |
| 106 | ATR | 0.40774391 |
| 107 | CAMKK1 | 0.40739988 |
| 108 | PRKG2 | 0.38921965 |
| 109 | MAPK11 | 0.36670282 |
| 110 | MAPK7 | 0.36407514 |
| 111 | MAP2K2 | 0.36118777 |
| 112 | CDC7 | 0.35951976 |
| 113 | SCYL2 | 0.34781991 |
| 114 | PDK1 | 0.34493486 |
| 115 | FGR | 0.34343148 |
| 116 | CAMKK2 | 0.34312069 |
| 117 | EIF2AK2 | 0.33603857 |
| 118 | BUB1 | 0.33130458 |
| 119 | * ABL1 | 0.31614689 |
| 120 | CDK6 | 0.31371624 |
| 121 | PASK | 0.31299238 |
| 122 | WEE1 | 0.31269283 |
| 123 | RAF1 | 0.31173064 |
| 124 | RPS6KA6 | 0.29323339 |
| 125 | PRKCH | 0.29113556 |
| 126 | * PRKCQ | 0.28656434 |
| 127 | TRPM7 | 0.28320663 |
| 128 | DYRK3 | 0.28250703 |
| 129 | ALK | 0.27956740 |
| 130 | STK11 | 0.27021192 |
| 131 | EGFR | 0.26014382 |
| 132 | IGF1R | 0.25229101 |
| 133 | CDK9 | 0.24823218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.12032619 |
| 2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.80949541 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.57654403 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.54742093 |
| 5 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.48936393 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.33506689 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.33310886 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.17257098 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15072931 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.10621885 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09397416 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.06070873 |
| 13 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.94592556 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90440108 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.82262542 |
| 16 | Ribosome_Homo sapiens_hsa03010 | 1.80172051 |
| 17 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.79666685 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.78616940 |
| 19 | Mismatch repair_Homo sapiens_hsa03430 | 1.76596635 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.73293661 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70892449 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69291684 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.64579709 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.61482731 |
| 25 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53315504 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53294594 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.50659796 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.45374980 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.44447551 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.41287882 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.38351454 |
| 32 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.37803742 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.37001751 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36782396 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.30286399 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.26846752 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.24635911 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.23653559 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23210964 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22411782 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.17174359 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16182981 |
| 43 | Malaria_Homo sapiens_hsa05144 | 1.15209921 |
| 44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.08831810 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.08181624 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04569903 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.02548354 |
| 48 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00483453 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00350599 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.99893106 |
| 51 | Spliceosome_Homo sapiens_hsa03040 | 0.99669331 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98960879 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.98300983 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95819346 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.95032255 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.92255059 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.90854771 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90101328 |
| 59 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.82462900 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.76923374 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76666814 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75646997 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75181674 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73452461 |
| 65 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70878310 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70869180 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.70697178 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69743909 |
| 69 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69310707 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68409396 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67182945 |
| 72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66392023 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.64686195 |
| 74 | Proteasome_Homo sapiens_hsa03050 | 0.62718287 |
| 75 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60379490 |
| 76 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58676296 |
| 77 | Cell cycle_Homo sapiens_hsa04110 | 0.58490728 |
| 78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55334324 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54249335 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.53569867 |
| 81 | RNA polymerase_Homo sapiens_hsa03020 | 0.53327385 |
| 82 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53029873 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.53010204 |
| 84 | Endocytosis_Homo sapiens_hsa04144 | 0.52658581 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50704614 |
| 86 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.49309279 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.49051472 |
| 88 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48100243 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47565366 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.45234974 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45092567 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44814320 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43362646 |
| 94 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42357634 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.41072175 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40908629 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40899512 |
| 98 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40494969 |
| 99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39665897 |
| 100 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38741591 |
| 101 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36873598 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36489440 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.35853043 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34530855 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33930359 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33232807 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33138781 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32587395 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31612823 |
| 110 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30985769 |
| 111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30896762 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30880848 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30327603 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30064018 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29347028 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28653961 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.28457665 |
| 118 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.28246974 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.27355721 |
| 120 | Endometrial cancer_Homo sapiens_hsa05213 | 0.27074281 |
| 121 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26392236 |
| 122 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.25346417 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19937373 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.19871599 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17306042 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.17063372 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.15797992 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.14258790 |

